Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anal lesions in hematologic diseases.

R Vanhueverzwyn, A Delannoy, J L Michaux

    Diseases of the Colon and Rectum
    |July 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial.

    Immuno-oncology technology·2024
    Same author

    Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.

    ESMO open·2022
    Same author

    iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms.

    Cancer cell international·2021
    Same author

    Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005].

    ESMO open·2021
    Same author

    Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.

    ESMO open·2021
    Same author

    How liquid biopsies can change clinical practice in oncology.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019

    Severe anal lesions affect 5% of patients with hematologic diseases, often appearing first and requiring surgical intervention for abscesses. Prognosis depends on the underlying blood disorder.

    Area of Science:

    • Hematology
    • Gastroenterology
    • Surgical Oncology

    Background:

    • Severe anal lesions are a potential complication in patients hospitalized with hematologic diseases.
    • These lesions can manifest as perianal infiltration, ulceration, and abscesses.
    • The occurrence rate of anal lesions in this cohort was 5%.

    Purpose of the Study:

    • To investigate the incidence and characteristics of severe anal lesions in patients with hematologic diseases.
    • To determine the relationship between anal lesions and the underlying hematologic condition.
    • To evaluate the efficacy of surgical management for anal abscesses in this patient population.

    Main Methods:

    • Retrospective analysis of 514 patients hospitalized for hematologic diseases.
    • Identification and classification of severe anal lesions.

    Related Experiment Videos

  • Review of treatment and outcomes, including surgical intervention for abscesses.

    • Main Results:

    • 31 patients (5%) developed severe anal lesions, most commonly in cases of agranulocytosis, acute myeloid leukemia, and medullar aplasia.
    • Anal lesions were the initial presenting symptom in 20% of affected patients.
    • Surgical therapy for abscesses resulted in rapid symptomatic improvement without complications.

    Conclusions:

    • Severe anal lesions are a significant, albeit uncommon, complication of hematologic diseases.
    • The presence and severity of anal lesions are linked to the prognosis of the underlying hematologic condition.
    • Surgical management of anal abscesses in these patients is safe and effective, leading to prompt symptom relief.